J&J's COVID vaccine taken by 19 MILLION Americans is pulled by FDA due to ... trends now
The Food and Drug Administration (FDA) has revoked authorization of Johnson & Johnson’s Covid vaccine after it was paused over rare blood clot concerns, which sent demand plummeting.
The move was not unexpected because J&J’s parent company Jannsen had requested that federal regulators at the FDA withdraw authorization for its vaccine after it was revealed that the last tranche of doses – about 12.5 million – had expired.
As of year three of the Covid pandemic, nearly 231 million Americans have received either one J&J shot or two doses of an mRNA vaccine from Pfizer or Moderna.
Vaccination fatigue has swept the US, with millions of Americans frustrated to learn that a shot does not guarantee immunity from the virus but rather protects against severe illness, and those people who planned on getting vaccinated are believed to have done so by now.
With a renewed wave of demand for J&J’s single-dose vaccine highly unlikely, coupled with a beleaguered history of production hiccups and health concerns that severely eroded public trust, the pharmaceutical company has opted to step away from the Covid vaccine field.
J&J's single shot vaccine faced myriad manufacturing hiccups early on resulting in the disposal of about 60 million doses after a Baltimore plant was found to have contaminated millions. The shot's association with rare but severe blood clotting cases sealed its fate as many Americans' last choice for a vaccine
A paucity of Americans have received J&J's vaccine compared the numbers who got one of the mRNA vaccines from Pfizer and Moderna
Citing ever-shrinking demand, J&J told the FDA it would not update formulations of its shot to confront emerging strains better, a step that Moderna and Pfizer took last year to address the devastating omicron variant.
Dr Peter Marks, Director of the FDA’s Center for Biologics Evaluation and Research said: ‘Because FDA understands that… Janssen Biotech, Inc. has requested that FDA withdraw the EUA for the Janssen COVID-19 Vaccine, FDA has determined that it is appropriate to protect the public health or safety to revoke this authorization.’
A fraction of Americans have received J&J’s vaccine compared to the other vaccines approved for use in the US.
Nearly 367 million Americans have received a Pfizer shot while over 232 million have received a dose of Moderna’s vaccine. A paucity of the total shots administered in the US since early 2021 – just over 19 million – were made by J&J.
Johnson & Johnson’s vaccine was plagued by controversy since it entered the market in February 2021. By that time, more than 2.1 million mRNA shots had already been administered and those from Pfizer and Moderna became the gold standard.
Less than a month after
